IVBXF
Price
$11.43
Change
-$0.04 (-0.35%)
Updated
Jul 18 closing price
Capitalization
19.39B
WXXWY
Price
$7.30
Change
+$0.12 (+1.67%)
Updated
Jul 18 closing price
Capitalization
14.72B
35 days until earnings call
Interact to see
Advertisement

IVBXF vs WXXWY

Header iconIVBXF vs WXXWY Comparison
Open Charts IVBXF vs WXXWYBanner chart's image
Innovent Biologics
Price$11.43
Change-$0.04 (-0.35%)
Volume$3.03K
Capitalization19.39B
Wuxi Biologics (Cayman)
Price$7.30
Change+$0.12 (+1.67%)
Volume$17.35K
Capitalization14.72B
IVBXF vs WXXWY Comparison Chart in %
Loading...
IVBXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WXXWY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IVBXF vs. WXXWY commentary
Jul 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IVBXF is a Hold and WXXWY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 21, 2025
Stock price -- (IVBXF: $11.43 vs. WXXWY: $7.30)
Brand notoriety: IVBXF and WXXWY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IVBXF: 8% vs. WXXWY: 62%
Market capitalization -- IVBXF: $19.39B vs. WXXWY: $14.72B
IVBXF [@Biotechnology] is valued at $19.39B. WXXWY’s [@Biotechnology] market capitalization is $14.72B. The market cap for tickers in the [@Biotechnology] industry ranges from $293.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IVBXF’s FA Score shows that 0 FA rating(s) are green whileWXXWY’s FA Score has 1 green FA rating(s).

  • IVBXF’s FA Score: 0 green, 5 red.
  • WXXWY’s FA Score: 1 green, 4 red.
According to our system of comparison, WXXWY is a better buy in the long-term than IVBXF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IVBXF’s TA Score shows that 3 TA indicator(s) are bullish while WXXWY’s TA Score has 4 bullish TA indicator(s).

  • IVBXF’s TA Score: 3 bullish, 4 bearish.
  • WXXWY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, WXXWY is a better buy in the short-term than IVBXF.

Price Growth

IVBXF (@Biotechnology) experienced а +12.28% price change this week, while WXXWY (@Biotechnology) price change was +7.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.68%. For the same industry, the average monthly price growth was +13.07%, and the average quarterly price growth was +34.43%.

Reported Earning Dates

WXXWY is expected to report earnings on Aug 25, 2025.

Industries' Descriptions

@Biotechnology (+2.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IVBXF($19.4B) has a higher market cap than WXXWY($14.7B). IVBXF YTD gains are higher at: 154.000 vs. WXXWY (64.879).
IVBXFWXXWYIVBXF / WXXWY
Capitalization19.4B14.7B132%
EBITDAN/AN/A-
Gain YTD154.00064.879237%
P/E RatioN/A33.60-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
IVBXF vs WXXWY: Fundamental Ratings
IVBXF
WXXWY
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
72
Overvalued
PROFIT vs RISK RATING
1..100
63100
SMR RATING
1..100
9661
PRICE GROWTH RATING
1..100
3536
P/E GROWTH RATING
1..100
1005
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IVBXF's Valuation (65) in the null industry is in the same range as WXXWY (72). This means that IVBXF’s stock grew similarly to WXXWY’s over the last 12 months.

IVBXF's Profit vs Risk Rating (63) in the null industry is somewhat better than the same rating for WXXWY (100). This means that IVBXF’s stock grew somewhat faster than WXXWY’s over the last 12 months.

WXXWY's SMR Rating (61) in the null industry is somewhat better than the same rating for IVBXF (96). This means that WXXWY’s stock grew somewhat faster than IVBXF’s over the last 12 months.

IVBXF's Price Growth Rating (35) in the null industry is in the same range as WXXWY (36). This means that IVBXF’s stock grew similarly to WXXWY’s over the last 12 months.

WXXWY's P/E Growth Rating (5) in the null industry is significantly better than the same rating for IVBXF (100). This means that WXXWY’s stock grew significantly faster than IVBXF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IVBXFWXXWY
RSI
ODDS (%)
Bearish Trend 3 days ago
63%
Bearish Trend 3 days ago
68%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
62%
Bearish Trend 3 days ago
73%
Momentum
ODDS (%)
Bullish Trend 3 days ago
62%
Bullish Trend 3 days ago
80%
MACD
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
61%
Bullish Trend 3 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
60%
Bullish Trend 3 days ago
76%
Advances
ODDS (%)
N/A
Bullish Trend 3 days ago
77%
Declines
ODDS (%)
Bearish Trend 11 days ago
61%
Bearish Trend 5 days ago
76%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
70%
Bearish Trend 3 days ago
69%
Aroon
ODDS (%)
Bullish Trend 3 days ago
62%
Bullish Trend 3 days ago
70%
View a ticker or compare two or three
Interact to see
Advertisement
IVBXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WXXWY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UNM81.120.69
+0.86%
Unum Group
ENTO0.47N/A
-0.08%
Entero Therapeutics Inc.
PNNT7.28-0.03
-0.41%
Pennant Investment Corp
HBI4.51-0.05
-1.10%
Hanesbrands
XOS3.37-0.09
-2.60%
Xos

IVBXF and

Correlation & Price change

A.I.dvisor tells us that IVBXF and WXXWY have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IVBXF and WXXWY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IVBXF
1D Price
Change %
IVBXF100%
-0.35%
WXXWY - IVBXF
24%
Poorly correlated
+1.67%
BNTC - IVBXF
23%
Poorly correlated
-5.96%
MBXBF - IVBXF
7%
Poorly correlated
N/A
ISCO - IVBXF
5%
Poorly correlated
-23.74%
IDRSF - IVBXF
4%
Poorly correlated
-0.33%
More

WXXWY and

Correlation & Price change

A.I.dvisor tells us that WXXWY and WXIBF have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that WXXWY and WXIBF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WXXWY
1D Price
Change %
WXXWY100%
+1.67%
WXIBF - WXXWY
32%
Poorly correlated
+12.73%
ELVAF - WXXWY
31%
Poorly correlated
N/A
CLYYF - WXXWY
25%
Poorly correlated
N/A
IVBXF - WXXWY
24%
Poorly correlated
-0.35%
COEP - WXXWY
23%
Poorly correlated
-5.15%
More